Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growt...
Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer
About this item
Full title
Author / Creator
Publisher
American Society for Clinical Investigation
Journal title
Language
English
Formats
Publication information
Publisher
American Society for Clinical Investigation
More information
Scope and Contents
Contents
The mainstay in the management of invasive bladder cancer continues to be radical cystectomy. With regard to improvement of quality of life, however, therapies that preserve the bladder are desirable. We investigated the use of intravesical PLK-1 small interfering RNA (siRNA) against bladder cancer. Patients with bladder cancers expressing high lev...
Alternative Titles
Full title
Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1062892
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1062892
Other Identifiers
ISSN
0021-9738
DOI
10.1172/JCI200523043
